|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Opiates, Expanded, Urine
Test Code15475
CPT Codes
80361, 80365
Includes
Codeine, Hydrocodone, Oxycodone, Morphine, Hydromorphone, Oxymorphone
Preferred Specimen
10 mL random urine collected in a plastic, leak-proof container
Minimum Volume
7 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Refrigerated: 7 days
Frozen: 6 months
Methodology
Gas Chromatography/Mass Spectrometry (GC/MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report available: Next day
Reference Range
See Laboratory Report
Clinical Significance
Opiates are used in medicine primarily for analgesia. They are prescribed extensively for the management of chronic pain, and acute pain from injury and surgical procedures, and for the relief of chronic and breakthrough pain, experienced by cancer patients.
This test is used to determine patient compliance with narcotic (opiate) prescriptions for Oxycodone and/or Oxymorphone. This test is often used in conjunction with an immunoassay screening procedure to verify the presence of a specific drug. Compliance with prescriptions for controlled substances is a major concern for physicians who prescribe them for patients.
This test is used to determine patient compliance with narcotic (opiate) prescriptions for Oxycodone and/or Oxymorphone. This test is often used in conjunction with an immunoassay screening procedure to verify the presence of a specific drug. Compliance with prescriptions for controlled substances is a major concern for physicians who prescribe them for patients.